Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer

• Published in: Cells (Basel, Switzerland) Switzerland), 2022-04, Vol.11 (9), p.1382
• Main Authors: Kołat, Damian, Kałuzińska, Żaneta, Bednarek, Andrzej K, Płuciennik, Elżbieta
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Antibiotics; AP-2α; AP-2γ; Bladder cancer; Cancer; Carcinogenesis; Fibroblast growth factor receptors; Gene expression; Life sciences; MAP kinase; Medical research; Next-generation sequencing; Phenotypes; Phosphatase; Proteins; Rap1 protein; Signal transduction; Stat6 protein; target genes; TFAP2A; TFAP2C; Transcription factors; Tumors; Wnt protein; WWOX
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11091382

Following the invention of high-throughput sequencing, cancer research focused on investigating disease-related alterations, often inadvertently omitting tumor heterogeneity. This research was intended to limit the impact of heterogeneity on conclusions related to WWOX/AP-2α/AP-2γ in bladder cancer which differently influenced carcinogenesis. The study examined the signaling pathways regulated by WWOX-dependent AP-2 targets in cell lines as biological replicates using high-throughput sequencing. RT-112, HT-1376 and CAL-29 cell lines were subjected to two stable lentiviral transductions. Following CAGE-seq and differential expression analysis, the most important genes were identified and functionally annotated. Western blot was performed to validate the selected observations. The role of genes in biological processes was assessed and networks were visualized. Ultimately, principal component analysis was performed. The studied genes were found to be implicated in MAPK, Wnt, Ras, PI3K-Akt or Rap1 signaling. Data from pathways were collected, explaining the differences/similarities between phenotypes. , , , , and were successfully validated at the protein level. Afterwards, a definitive network was built using 173 genes. Principal component analysis revealed that the various expression of these genes explains the phenotypes. In conclusion, the current study certified that the signaling pathways regulated by WWOX and AP-2α have more in common than that regulated by AP-2γ. This is because WWOX acts as an EMT inhibitor, AP-2γ as an EMT enhancer while AP-2α as a MET inducer. Therefore, the relevance of AP-2γ in targeted therapy is now more evident. Some of the differently regulated genes can find application in bladder cancer treatment.